BioSyent Inc.
BIOYF
$11.35
-$0.05-0.43%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 90.19% | 30.74% | 10.40% | 26.65% | 12.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 90.19% | 30.74% | 10.40% | 26.65% | 12.55% |
| Cost of Revenue | 153.70% | 46.11% | 36.12% | 41.39% | 19.65% |
| Gross Profit | 72.00% | 25.87% | 4.50% | 22.58% | 10.67% |
| SG&A Expenses | 69.08% | 26.40% | 11.08% | 21.59% | -2.24% |
| Depreciation & Amortization | 380.61% | 139.02% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 101.91% | 34.43% | 17.54% | 27.59% | 7.28% |
| Operating Income | 55.42% | 20.67% | -8.26% | 24.30% | 31.78% |
| Income Before Tax | 40.85% | 7.42% | 10.56% | 21.47% | 26.30% |
| Income Tax Expenses | 50.05% | 16.04% | -23.40% | 43.54% | 26.30% |
| Earnings from Continuing Operations | 37.54% | 4.31% | 23.98% | 15.09% | 26.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.54% | 4.31% | 23.98% | 15.09% | 26.31% |
| EBIT | 55.42% | 20.67% | -8.26% | 24.30% | 31.78% |
| EBITDA | 76.98% | 26.73% | -3.03% | 26.88% | 34.21% |
| EPS Basic | 35.88% | 3.70% | 26.65% | 18.42% | 30.12% |
| Normalized Basic EPS | 44.92% | 15.66% | -5.19% | 24.98% | 30.11% |
| EPS Diluted | 35.61% | 3.71% | 25.99% | 18.32% | 29.93% |
| Normalized Diluted EPS | 45.04% | 15.49% | -5.58% | 24.89% | 29.53% |
| Average Basic Shares Outstanding | 1.23% | 0.59% | -2.04% | -2.82% | -2.93% |
| Average Diluted Shares Outstanding | 1.13% | 0.71% | -1.75% | -2.67% | -2.51% |
| Dividend Per Share | 7.20% | 13.79% | 11.84% | 10.00% | 9.73% |
| Payout Ratio | -0.21% | 0.09% | -0.11% | -0.07% | -0.15% |